Form 4: Bio-Techne Director Amy E. Herr Reports Stock Option Exercise and Sale
SEC Form 4
Director Amy E. Herr reports exercising stock options and selling shares of Bio-Techne Corp, along with details of her direct and indirect holdings.
Summary
- On February 14, 2025, Amy E. Herr, a director of Bio-Techne Corp, executed transactions involving the company's stock.
- Herr exercised stock options to acquire 1,976 shares of common stock at a price of $44.33 per share.
- Simultaneously, she sold 1,860 shares of common stock at $65.9627 per share.
- Following these transactions, Herr directly owns 1,040 shares and indirectly owns 1,976 shares through a significant other.
- Herr also holds various stock options and restricted stock units, vesting at different dates and prices, indirectly through a significant other.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard insider trading disclosure. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key individuals within the company.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
- The reported transactions are typical for executives who receive stock options as part of their compensation packages.
- Comparable companies like Thermo Fisher Scientific or Danaher also have similar insider trading disclosures.
Stakeholder Impact
- The transactions may have a minor impact on shareholders as they provide insight into the director's perspective on the company's stock value.
- The impact on employees, customers, suppliers, and creditors is likely negligible.
Key Dates
| Date | Description |
|---|---|
| 02/03/2025 | Date of stock option grant with exercise price of $72.05 |
| 02/14/2025 | Date of transaction: stock option exercise and sale of shares |
| 08/08/2025 | Expiration date for stock options with exercise price of $44.33 |
| 08/07/2026 | Expiration date for stock options with exercise price of $47.6 |
| 08/05/2027 | Expiration date for stock options with exercise price of $66.97 |
| 08/06/2028 | Expiration date for stock options with exercise price of $120.46 |
| 08/15/2029 | Expiration date for stock options with exercise price of $94.52 |
| 08/15/2030 | Expiration date for stock options with exercise price of $84.61 |
| 08/15/2034 | Expiration date for stock options with exercise price of $74.91 |
| 02/03/2035 | Expiration date for stock options with exercise price of $72.05 |
| 02/18/2025 | Date of filing |
Keywords
Form 4, BIO-TECHNE Corp, Stock Options, Insider Trading, Amy E. Herr, Director, TECH, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.